Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 21:15:1563073.
doi: 10.3389/fonc.2025.1563073. eCollection 2025.

A multimodal nomogram for benign-malignant discrimination of lung-RADS ≥4A nodules: integration of oxygen enhanced zero echo time MRI, CT radiomics, and clinical factors

Affiliations

A multimodal nomogram for benign-malignant discrimination of lung-RADS ≥4A nodules: integration of oxygen enhanced zero echo time MRI, CT radiomics, and clinical factors

Tiancai Yan et al. Front Oncol. .

Abstract

Background and objective: Lung-RADS ≥4A nodules require urgent intervention. Low-dose CT (LDCT), the primary screening tool, involves cumulative radiation exposure-critical for patients with serial scans. Oxygen-enhanced zero-echo time MRI (OE-ZTE-MRI) shows potential for lung nodule evaluation. However, its additive value when combined with CT radiomics and clinical factors for Lung-RADS ≥4A nodules remains unproven. This study aimed to develop a preoperative prediction model integrating OE-ZTE-MRI/CT radiomics and clinical factors for benign-malignant discrimination of Lung-RADS ≥4A nodules and compare its performance against single-modality models.

Methods: 99 nodules from 84 prospectively enrolled patients undergoing both LDCT and OE-ZTE-MRI were included. Nodule boundaries were manually contoured as regions of interest (ROIs) on both modalities. Six machine learning classifiers were applied to radiomic features (extracted from LDCT and OE-ZTE-MRI) and clinical parameters (age, smoking history, nodule diameter, calcification, etc.). Model performance was evaluated using receiver operating characteristic (ROC) curves with area under the curve (AUC), complemented by decision curve analysis (DCA). Univariate and multivariate logistic regression identified independent predictors, which were incorporated into a final nomogram to visualize clinical-radiomic prediction.

Results: MRI model had a similar diagnostic performance to CT model (MRI vs. CT: training cohort AUC: 0.854 vs 0.907; testing cohort AUC: 0.769 vs 0.798). Multi-radiomics model achieved the highest diagnostic efficiency (train cohort AUC:0.923; testing cohort AUC: 0.813). Multivariate Logistic regression showed that nodule diameter (p=0.005) and calcification (p=0.029) were important factors affecting the benign and malignant nodules. The nomogram constructed by 3 models(CT/OE-ZTE-MRI/Clinical factors) achieved the best preoperative prediction performance for benign and malignant nodules (training cohort: AUC 0.941; testing cohort AUC:0.838).

Conclusion: The nomogram combining OE-ZTE-MRI/CT radiomics and clinical factors (nodule diameter, calcification) improves preoperative discrimination of Lung-RADS ≥4A nodules (AUC=0.838), outperforming single-modality models. This tool enables evidence-based triage, potentially reducing unnecessary invasive procedures.

Keywords: CT; MRI; multimodel analysis; oxygen enhanced; radiomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of patient enrollment in this study.
Figure 2
Figure 2
Workflow of radiomic analysis in the study. Radiologists segmented nodules, and LASSO selected features based on which the prediction model, MSE, and weight were built. Finally, the Combined Model, Calibration, and nomogram were built. Example figures (A, C) are CT images of the benign and malignant groups, respectively, while figures (B, D) are OE-ZTE-MRI images of the benign and malignant groups, respectively.
Figure 3
Figure 3
Retained radiomics features and their corresponding coefficients in different models after regression analysis by LASSO. (A) OE-ZTE-MRI model,(B) CT model, (C) CT-MRI model.
Figure 4
Figure 4
Decision Curve Analysis of MRI radiomic models. CT radiomic models and CT_MRI model for predicting Benign and Malicious in (A) training and (B) testing.
Figure 5
Figure 5
ROC curves of 5 models in the (A) training and (B) testing.
Figure 6
Figure 6
Decision Curve Analysis of 5 models for predicting Benign and Malicious in (A) training and (B) testing.
Figure 7
Figure 7
Nomogram of Combined Model. The sum of all factors equals the total points.CT_MRI: CT &OE-ZTE-MRI. Combined Model: CT sequences, OE-ZTE-MRI sequences, calcification and age. Among them, the nodule diameter is based on a zero baseline of 10mm.
Figure 8
Figure 8
An example of a Nomogram of Combined Model. The CT-MR model predicted a 40% probability of malignancy in a patient with a pulmonary lesion. The nodule has no calcification and a diameter of approximately 40mm. After analysis using the nomogram, the malignancy rate for this patient increased to about 70%.

Similar articles

References

    1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. (2024) 74:229–63. doi: 10.3322/caac.21834, PMID: - DOI - PubMed
    1. Kim JS, Gupta R. Clinical manifestations and management of fibrotic pulmonary sarcoidosis. J Clin Med. (2023) 13. doi: 10.3390/jcm13010241, PMID: - DOI - PMC - PubMed
    1. Iaccarino JM, Simmons J, Gould MK, Slatore CG, Woloshin S, Schwartz LM, et al. Clinical equipoise and shared decision-making in pulmonary nodule management. A survey of american thoracic society clinicians. Ann Am Thorac Soc. (2017) 14:968–75. doi: 10.1513/AnnalsATS.201609-727OC, PMID: - DOI - PMC - PubMed
    1. Mankidy BJ, Mohammad G, Trinh K, Ayyappan AP, Huang Q, Bujarski S, et al. High risk lung nodule: A multidisciplinary approach to diagnosis and management. Respir Med. (2023) 214:107277. doi: 10.1016/j.rmed.2023.107277, PMID: - DOI - PubMed
    1. Hirsch FW, Sorge I, Vogel-Claussen J, Roth C, Gräfe D, Päts A, et al. The current status and further prospects for lung magnetic resonance imaging in pediatric radiology. Pediatr Radiol. (2020) 50:734–49. doi: 10.1007/s00247-019-04594-z, PMID: - DOI - PMC - PubMed

LinkOut - more resources